ConvaTec Group Plc (CTEC.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold CTEC.L in your mock portfolio yet.
With a PE ratio of 16.62 and EPS of 0.14, ConvaTec Group Plc appears reasonably valued relative to typical mature medtech/healthcare names, suggesting neither clear undervaluation nor overvaluation based solely on earnings. The modest EPS level implies the company is profitable but not generating outsized earnings power, pointing to a steady, incremental growth profile rather than a high-growth story. Without additional revenue and margin history, the data suggest stable but not spectacular financial performance.
The stock is trading at $226.00, just above its 200-day moving average of $225.09, and is up 5.0% over the last month, indicating a mild positive short-term trend but no decisive breakout. An RSI of 47.89 is near the midpoint, suggesting neither overbought nor oversold conditions and implying a balanced technical setup. Overall, the technical picture is stable and slightly constructive, but not strongly bullish.
Website traffic at an estimated 16,386 visitors per month appears modest for a global medtech company, offering limited evidence of surging top-of-funnel demand. Job openings at 152, down 3.2% month over month, suggest a slight cooling or normalization in hiring rather than aggressive expansion. Social media followings are largest on LinkedIn and show slow but positive growth across platforms, indicating stable brand presence without a strong acceleration signal.
Across fundamentals, technicals, and alternative data, ConvaTec Group Plc presents a balanced risk/reward profile with no dominant bullish or bearish signal. Valuation and earnings suggest a mature, steadily profitable business, while price action and alternative data indicate stability rather than strong acceleration. Overall, the evidence points to a neutral outlook, with future direction likely driven by upcoming fundamental catalysts rather than current positioning.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started